Related Experiment Video
Updated: May 19, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
P53 and cellular glucose uptake
Alejandro J de la Torre1, Daniela Rogoff, Perrin C White
1Division of Pediatric Endocrinology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9063, USA.
Objectives:
Tumor protein p53 is a transcription factor involved with cellular responses to stressors including limited glucose availability. We hypothesized that modulating p53 levels would affect cellular glucose uptake.
Methods And Results:
Transfecting cultured primary mouse hepatocytes with p53 siRNA suppressed p53 mRNA expression >90%. Control hepatocytes (transfected with non-targeting siRNA) increased glucose uptake (2.28 ± 1.02-fold vs basal, p 0.009) in response to 100 nM insulin, but p53 siRNA-treated hepatocytes had a blunted response (0.92 ± 0.11-fold vs basal; between group difference p 0.0012). In adipocytes differentiated from the pre-adipocyte line 3T3-L1, knockdown of p53 had no effect on insulin-stimulated glucose uptake. There were no differences in Glut 1 or Glut 2 expression in the plasma membrane fraction or in the levels of phosphorylated AKT in cell lysates between primary hepatocytes transfected with p53 siRNA or control siRNA. Glycemic responses to insulin tolerance, glucose tolerance, and pyruvate tolerance tests did not differ between p53 knockout and wild type mice.
Discussion:
Thus, inhibition of p53 has pleiotropic effects, inhibiting glucose uptake in the liver but having no effect on adipocytes. Knockout of p53 has no apparent effect on glucose homeostasis in intact lean mice. An explanation for the association between p53 expression and hepatocyte glucose uptake remains to be elucidated.
Insights
Inhibition of tumor protein p53 (p53) blunts glucose uptake in liver cells but not fat cells. However, p53 knockout mice show normal glucose homeostasis, suggesting complex roles in glucose metabolism.
Area of Science:
- Cellular Biology
- Molecular Biology
- Metabolism
Background:
- Tumor protein p53 (p53) is a critical transcription factor responding to cellular stress.
- Limited glucose availability is a known stressor that can activate p53.
- The precise role of p53 in regulating glucose uptake remains incompletely understood.
Purpose of the Study:
- To investigate the hypothesis that modulating p53 levels affects cellular glucose uptake.
- To determine the impact of p53 inhibition on insulin-stimulated glucose uptake in hepatocytes and adipocytes.
- To assess the in vivo effects of p53 knockout on glucose homeostasis.
Main Methods:
- Primary mouse hepatocytes and 3T3-L1 adipocytes were treated with p53 siRNA to suppress p53 expression.
- Insulin-stimulated glucose uptake was measured in treated and control cells.
- Western blotting assessed Glut 1, Glut 2, and phosphorylated AKT levels.
- p53 knockout and wild-type mice underwent glucose and insulin tolerance tests.
Main Results:
- p53 siRNA significantly reduced p53 mRNA in hepatocytes, leading to a blunted insulin-stimulated glucose uptake compared to controls.
- In contrast, p53 knockdown had no effect on insulin-stimulated glucose uptake in 3T3-L1 adipocytes.
- No significant differences were observed in Glut 1, Glut 2, or p-AKT levels between groups.
- p53 knockout mice exhibited normal glycemic responses in tolerance tests.
Conclusions:
- p53 inhibition demonstrates tissue-specific effects, impairing hepatic glucose uptake while sparing adipocytes.
- Complete knockout of p53 does not appear to disrupt overall glucose homeostasis in lean mice.
- Further research is needed to elucidate the mechanisms linking p53 expression to hepatocyte glucose uptake.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Cell Specific Gene Expression
PI3K/mTOR/AKT Signaling Pathway
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle

